Please assess the completion status of the following clinical trial:

Trial Title: Hydrotherapy for the Reversal of Oligohydramnios

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Maternal Age \>18 years~* Oligohydramnios: diagnosed by sonography (defined AFV\<8cm)~* Singleton Pregnancy~* Intact membranes~* Gestational age 24 - 36 weeks~Exclusion Criteria:~* Indication for urgent delivery (severe PET, HELLP syndrome, persistent fetal hypoxemia \[non-reassuring fetal heart rate pattern\])~* Ruptured amniotic membranes; PPROM, PROM, SROM~* Fever (\>38C)~* Multiple gestation~* \>37 week gestation~* Lethal Fetal anomalies and/or demise~* Maternal Cardiovascular disease~* Maternal Renal disease~* Maternal Pulmonary disease (other than asthma)~* Patients using prostaglandin inhibitors, NSAIDs3,15 (within 1 week of enrollment, other than baby asprin)~* Non-English speaking~* Vaginal Infections and/or active skin lesions~* Placenta Previa and/or Unexplained Vaginal Bleeding~* BMI \> 45

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- IV/Oral Hydration and Bedrest (Type: ACTIVE_COMPARATOR): * Maternal BP (sitting)~* Pulse Pressure~* Pulse~* Urine Specific Gravity BID~* Fetal Heart Rate~* Maternal Body Weight US Procedures~* AC/EFW~* Umbilical Artery Doppler Flow (Baseline, day 3, 7 {or Discharge})~* Uterine Artery Doppler Flow (Baseline, day 3, 7 {or Discharge})~* AFI (Baseline, day 3, 7 {or Discharge})~ALL ITEMS ABOVE MUST BE COMPLETED BEFORE:~* 1 Liter Water PO over 2 hours~* 1 Liter IV Fluid Bolus (NS) then titrated to 75 ml\\hr for duration of the study participation~* Strict I/O's~* Vital signs
- Hydrotherapy Group (Type: ACTIVE_COMPARATOR): * Maternal BP (sitting)~* Pulse Pressure~* Pulse~* Urine Specific Gravity BID~* Fetal Heart Rate~* Maternal Body Weight US Procedures~* AC/EFW~* Umbilical Artery Doppler Flow (Baseline, day 3, 7 {or Discharge})~  o 1 hour +/- 30 minutes after submersion therapy~* Uterine Artery Doppler Flow (Baseline, day 3, 7 {or Discharge})~  o 1 hour +/- 30 minutes after submersion therapy~* AFI (Baseline, day 3, 7 {or Discharge}) o 1 hour +/- 30 minutes after submersion therapy~ALL ITEMS ABOVE MUST BE COMPLETED BEFORE:~* 1 Liter Water PO over 2 hours~* 1 Liter IV Fluid Bolus (NS) then titrated to 75 ml\\hr for duration of the study participation~* Strict I/O's~* Vital signs~* HYDROTHERAPY TWICE DAILY FOR 3-7 DAYS o Blood pressure, pulse, pulse pressure, body weight, and fetal heart rate before and after submersion therapy

Based on this trial design, predict the completion outcome and termination type (if applicable).